Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.30 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.30 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | GGT1 | P19440 | 1/20 | 0.30 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | LCK | P06239 | 1/20 | 0.30 |
| ▸ | FYN | P06241 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL5844205 | 0.97 | ALDH1A1 (0.31) | ALDH1A1TSHRKMT2A | |
| SCHEMBL5874788 | 0.78 | — | — | |
| SCHEMBL5875157 | 0.78 | — | — | |
| SCHEMBL7211813 | 0.77 | ALDH1A1 (0.41) | ALDH1A1TSHRELANEHPGD | |
| SCHEMBL4089506 | 0.75 | MTNR1A (0.36) | ALDH1A1KMT2AKDM4E | |
| Hydrochloric Acid SCHEMBL9652925 | 0.75 | ALDH1A1 (0.39) | ALDH1A1TSHRELANETDP1 | |
| SCHEMBL1505860 | 0.74 | MEN1 (0.30) | KMT2A | |
| SCHEMBL936386 | 0.74 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL4661613 | 0.73 | ELANE (0.35) | ALDH1A1KMT2AELANEKDM4EESR1 | |
| SCHEMBL5874532 | 0.73 | ALDH1A1 (0.30) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 715 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260071024-A1 | POLYPROPIOLACTONES AND METHODS OF PREPARATION | NOVOMER INC (US) | 2026-03-12 | — | — | US | claimed |
| US-20250171409-A1 | PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES | ADAMA MAKHTESHIM LTD. (IL) | 2025-05-29 | — | — | US | claimed |
| CN-119192566-A | Non-isocyanate polyurea and preparation method thereof, water-based non-isocyanate polyurea and preparation method thereof, and anti-corrosion coating, waterproof coating and fireproof coating containing water-based non-isocyanate polyurea and preparation method thereof | 山西省建筑科学研究院集团有限公司 | 2024-12-27 | — | — | CN | claimed |
| US-12173342-B2 | Method for producing monophosphoryl lipid A | EUBIOLOGICS CO., LTD. (KR) | 2024-12-24 | — | — | US | claimed |
| US-20240393290-A1 | ELECTROCHEMICAL GAS SENSOR AND ELECTROLYTE FOR AN ELECTROCHEMICAL GAS SENSOR | Dräger Safety AG & Co. KGaA (DE) | 2024-11-28 | — | — | US | claimed |
| CN-119019307-A | Vitamin D3Is prepared by the preparation method of (2) | 厦门金达威维生素有限公司 | 2024-11-26 | — | — | CN | claimed |
| EP-4460499-A1 | PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES | ADAMA MAKHTESHIM LTD. (IL) | 2024-11-13 | — | — | EP | claimed |
| CN-118771946-A | ADN/layered hydroxide composite, preparation method and application thereof | 中国万宝工程有限公司 | 2024-10-15 | — | — | CN | claimed |
| CN-118771947-A | HMX/layered hydroxide composite and preparation method and application thereof | 中国万宝工程有限公司 | 2024-10-15 | — | — | CN | claimed |
| CN-118754791-A | AP/layered hydroxide composite, preparation method and application thereof | 中国万宝工程有限公司 | 2024-10-11 | — | — | CN | claimed |
| EP-0429480-A4 | — | — | 1994-01-05 | — | — | EP | claimed |
| WO-1993017723-A1 | BIODEGRADABLE SURFACE DISINFECTANT | SIMMONS PAUL L (US) | 1993-09-16 | — | — | WO | claimed |
| EP-0429480-A1 | NATRIURETIC HORMONE | Bricker, Neal S (US) | 1991-06-05 | — | — | EP | claimed |
| US-4935558-A | Reductive dechlorination of 1,1,1,2-tetrafluoro-2-chloroethane | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-06-19 | — | — | US | claimed |
| WO-1990000394-A1 | NATRIURETIC HORMONE | LOMA LINDA UNIVERSITY (US) | 1990-01-25 | — | — | WO | claimed |
| US-4742161-A | RED DYES | SANDOZ LTD. (CH) | 1988-05-03 | — | — | US | claimed |
| US-4722842-A | Growth inhibitory factor | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1988-02-02 | — | — | US | claimed |
| US-4546176-A | 7-Carboxymethoxyphenylacetamido-3-cephem derivatives and antibacterial preparations containing the same | EISAI CO., LTD. (JP) | 1985-10-08 | — | — | US | claimed |
| US-4333884-A | Production of acetic anhydride | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-06-08 | — | — | US | claimed |
| US-4319038-A | BY REACTING METHYL ACETATE OR DIMETHYL ETHER WITH CARBON MONOXIDE AND HYDROGEN IN THE PRESENCE OF A CATALYST SYSTEM WHICH INCLUDES AN ALIPHATIC CARBOXYLIC ACID, A MANGANESE OR RHEMIUM COMPOUND, AND A HETEROCYCLIC NITROGEN-CONTAINING SALT | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-03-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071024-A1 | POLYPROPIOLACTONES AND METHODS OF PREPARATION | NOTUM, ALKBH3, EBP | ALDH1A1 561/4885TSHR 3633/4885KMT2A 3087/4885 |
| US-20250171409-A1 | PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES | DDT, IDO2, INSR | ALDH1A1 1545/4885TSHR 407/4885KMT2A 3649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.